Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant vs Glimepiride in Overweight/Obese Type 2 Diabetes
NCT00449605Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Mar 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of rimonabant in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Mar 2007; status: terminated.
02
Drugs
rimonabant
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00449605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449605.